MAST CELL ACTIVATION SYNDROME

This adverse event was reported 161 times

These drugs are most commonly taken by patients reporting MAST CELL ACTIVATION SYNDROME:

# Drug Count
0 IBUPROFEN 200MG 20
1 DIPHENHYDRAMINE CITRATE, IBUPROFEN 18
2 IBUPFROFEN 18
3 IBUPROFEN 18
4 IBUPROFEN 200 MG 18
5 RANITIDINE HYDROCHLORIDE 18
6 DICLOFENAC SODIUM 17
7 DICLOFENAC 16
8 ALBUTEROL SULFATE 15
9 SODIUM OXYBATE 15
See all common drugs associated with MAST CELL ACTIVATION SYNDROME

These drug classes are most commonly taken by patients reporting MAST CELL ACTIVATION SYNDROME:

# Drug class Count
0 Insulin Analog [EPC] 2
1 Tetracycline-class Drug [EPC] 2
2 Vitamin B6 Analog [EPC] 1
See all common drug classes associated with MAST CELL ACTIVATION SYNDROME

MAST CELL ACTIVATION SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin B6 Analog [EPC] 1 0.0020
1 Tetracycline-class Drug [EPC] 2 0.0001
2 Insulin Analog [EPC] 2 0.0000
See all drug classes enriched for association with MAST CELL ACTIVATION SYNDROME